Biotechnology company

CEO Profile
CEO Profile
송동호 대표이사
President/CEO David Song
Highly-qualified professional with more than 30 years of experience, expertise, and knowhow related to the development of biological products home and abroad
Greetings     >

College of Veterinary Medicine, B.S./M.S. / Seoul National University (Korea)

College of Veterinary Medicine, Ph.D. course work completed / Seoul National University (Korea)


Minister of Health and Social Affairs (1992)

Minister of Food and Drug Administration (2017)

Work Experience

Head of Biopharmaceutical Product Development / LG Life Sciences and Green Cross

Founder & CEO / PNS Bio and BIOCND


RA experience with the U.S. FDA, EU EMA, Canada BOB, and Korea MFDS

Consulting projects for more than 20 biological products for clinical trials or MA approval with domestic and overseas biotechnology or pharmaceutical companies

Global business network with overseas biopharmaceutical companies and institutions

Development / Consulting Projects
  • Recombinant Hepatitis B vaccine
  • Arranging technology transfer between Rhein Biotech, Germany, and Green Cross and obtaining MA approval to make it the top export product of the Korea pharmaceutical industry for the first 10 years in the market

  • Human growth hormone (hGH)
  • Obtaining MA approval as the 2nd biosimilar product in the U.S. and EU (LG Life Sciences)

  • Consulting projects
  • Overseas client : Optimer Biotech, Taiwan and the U.S. for IND approval from the Korea MFDS as part of the multi-national clinical studies

    Domestic clients : Dinona, Enzychem, Hugel, Celltrion, Pangen, ISUAbxis, Samsung Fine Chemicals, Eubiologics, TSbioetc.